Your browser doesn't support javascript.
loading
Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.
Davari, Danielle R; Orlow, Irene; Kanetsky, Peter A; Luo, Li; Edmiston, Sharon N; Conway, Kathleen; Parrish, Eloise A; Hao, Honglin; Busam, Klaus J; Sharma, Ajay; Kricker, Anne; Cust, Anne E; Anton-Culver, Hoda; Gruber, Stephen B; Gallagher, Richard P; Zanetti, Roberto; Rosso, Stefano; Sacchetto, Lidia; Dwyer, Terence; Ollila, David W; Begg, Colin B; Berwick, Marianne; Thomas, Nancy E.
Affiliation
  • Davari DR; Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kanetsky PA; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Luo L; Department of Internal Medicine, University of New Mexico Cancer Center, University of New Mexico, Albuquerque, New Mexico.
  • Edmiston SN; Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Conway K; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Parrish EA; Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Hao H; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Busam KJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Sharma A; Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Kricker A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Cust AE; Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Anton-Culver H; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gruber SB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gallagher RP; Sydney School of Public Health, The University of Sydney, Sydney, Australia.
  • Zanetti R; Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia.
  • Rosso S; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Sacchetto L; Department of Epidemiology, University of California, Irvine, Irvine, California.
  • Dwyer T; City of Hope National Medical Center, Duarte, California.
  • Ollila DW; BC Cancer and Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
  • Begg CB; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
  • Berwick M; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
  • Thomas NE; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Cancer Epidemiol Biomarkers Prev ; 30(12): 2309-2316, 2021 12.
Article in En | MEDLINE | ID: mdl-34607836
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Lymphocytes, Tumor-Infiltrating / Cyclin-Dependent Kinase Inhibitor p15 / Melanoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Epidemiol Biomarkers Prev Journal subject: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Lymphocytes, Tumor-Infiltrating / Cyclin-Dependent Kinase Inhibitor p15 / Melanoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Epidemiol Biomarkers Prev Journal subject: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Country of publication: Estados Unidos